25.04.2023 - SAWC Spring 2023 represents first clinical conference opportunity to introduce newly effective dedicated AC5 HCPCS reimbursement codeFRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) - Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the . Seite 1
Arch Therapeutics (OTCMKTS:ARTH – Get Rating) and Sintx Technologies (NASDAQ:SINT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings and valuation. Volatility and Risk Arch Therapeutics has a beta of […]
Arch Therapeutics (OTCMKTS:ARTH – Get Rating) and Retractable Technologies (NYSE:RVP – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends. Analyst Ratings This is a summary of current ratings […]